Showing results (111-120 of 129) with videos related to

Sort By:
Pageof 13
Current Cancer Drug Targets|December 15, 2011
The Hsp32 inhibitors SMA-ZnPP and PEG-ZnPP exert major growth-inhibitory effects on D34+/CD38+ and CD34+/CD38- AML progenitor cellsH Herrmann, M Kneidinger, S Cerny-Reiterer, et al.
Leukemia & Lymphoma|August 1, 2002
Serum tryptase measurements in patients with myelodysplastic syndromesW R Sperr, B Stehberger, F Wimazal, et al.
Blood|September 25, 2001
Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemiaW R Sperr, J H Jordan, M Baghestanian, et al.
Leukemia|January 17, 2017
Proposed diagnostic criteria and classification of basophilic leukemias and related disordersP Valent, K Sotlar, K Blatt, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 21, 2001
Genetic engineering of a hypoallergenic trimer of the major birch pollen allergen Bet v 1S Vrtala, K Hirtenlehner, M Susani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 26, 2017
Midostaurin: a magic bullet that blocks mast cell expansion and activationP Valent, C Akin, K Hartmann, et al.
Leukemia|June 10, 2015
Identification of bromodomain-containing protein-4 as a novel marker and epigenetic target in mast cell leukemiaG Wedeh, S Cerny-Reiterer, G Eisenwort, et al.
Leukemia|August 1, 2017
Nilotinib-induced vasculopathy: identification of vascular endothelial cells as a primary target siteE Hadzijusufovic, K Albrecht-Schgoer, K Huber, et al.
Leukemia|December 19, 2017
Drug-induced inhibition of phosphorylation of STAT5 overrides drug resistance in neoplastic mast cellsB Peter, S Bibi, G Eisenwort, et al.
Annals of Hematology|April 29, 2018
Consensus statement for cancer patients requiring intensive care supportM G Kiehl, G Beutel, B Böll, et al.
Pageof 13